Subhashis Banerjee, Chief Medical Officer at Artiva Biotherapeutics, Inc. (ARTV), sold 429 shares at $12.00 ($5K) on 2026-08-18, disclosed to the SEC on 2026-08-19.
Scheduled sale ($5k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARTV | SELL | 2026-08-31 | $99K | — | Filing → |
| ARTV | SELL | 2026-05-19 | $63K | — | Filing → |